2. Gene
  3. FLT4 - fms related receptor tyrosine kinase 4 Gene

FLT4 - fms related receptor tyrosine kinase 4 Gene

  • 基因
  • 蛋白
  • 相关产品
  • 直系同源

中文名称：fms 相关 受体酪氨酸激酶 4

种属: Felis catus

基因 ID: 101094727 | 基因类型: protein coding

关于 FLT4

FLT4 基因产物(3)

mRNA Protein Name
XM_006927498.5 XP_006927560.1 vascular endothelial growth factor receptor 3 isoform X3
XM_045057091.1 XP_044913026.1 vascular endothelial growth factor receptor 3 isoform X2
XM_006927499.5 XP_006927561.1 vascular endothelial growth factor receptor 3 isoform X1

FLT4 蛋白结构

Ig_2

Ig_2: pfam13895 (139 - 222)

IgI_VEGFR

IgI_VEGFR: cd05862 (232 - 236)

IgI_VEGFR

IgI_VEGFR: cd05862 (232 - 331)

IgI_VEGFR

IgI_VEGFR: cd05862 (242 - 246)

IgI_VEGFR

IgI_VEGFR: cd05862 (248 - 257)

IgI_VEGFR

IgI_VEGFR: cd05862 (264 - 269)

IgI_VEGFR

IgI_VEGFR: cd05862 (272 - 274)

IgI_VEGFR

IgI_VEGFR: cd05862 (278 - 286)

IgI_VEGFR

IgI_VEGFR: cd05862 (291 - 299)

IgI_VEGFR

IgI_VEGFR: cd05862 (309 - 315)

IgI_VEGFR

IgI_VEGFR: cd05862 (320 - 326)

IgI_VEGFR-3

IgI_VEGFR-3: cd05863 (333 - 420)

IgI_VEGFR-3

IgI_VEGFR-3: cd05863 (334 - 339)

IgI_VEGFR-3

IgI_VEGFR-3: cd05863 (344 - 349)

IgI_VEGFR-3

IgI_VEGFR-3: cd05863 (351 - 362)

IgI_VEGFR-3

IgI_VEGFR-3: cd05863 (366 - 372)

IgI_VEGFR-3

IgI_VEGFR-3: cd05863 (374 - 377)

IgI_VEGFR-3

IgI_VEGFR-3: cd05863 (380 - 382)

IgI_VEGFR-3

IgI_VEGFR-3: cd05863 (384 - 389)

IgI_VEGFR-3

IgI_VEGFR-3: cd05863 (397 - 405)

IgI_VEGFR-3

IgI_VEGFR-3: cd05863 (411 - 420)

IG_like

IG_like: smart00410 (566 - 659)

Ig

Ig: cd00096 (576 - 580)

Ig

Ig: cd00096 (589 - 593)

Ig

Ig: cd00096 (638 - 642)

Ig

Ig: cd00096 (652 - 657)

IG_like

IG_like: smart00410 (688 - 767)

Ig

Ig: cd00096 (697 - 701)

Ig

Ig: cd00096 (710 - 714)

Ig

Ig: cd00096 (733 - 737)

Ig

Ig: cd00096 (747 - 752)

VEGFR-2_TMD

VEGFR-2_TMD: pfam17988 (772 - 806)

PKc_like

PKc_like: cl21453 (839 - 1177)

  • 0
  • 300
  • 600
  • 900
  • 1200
  • 1365 a.a.
蛋白主名 其他名称

vascular endothelial growth factor receptor 3

fms related tyrosine kinase 4

相关产品

Approval
生物活性分子 (3)
目录号 产品名 作用方式
纯度 是否罕见病
HY-10260 Vandetanib 99.95% 是
HY-10260B Vandetanib hydrochloride / 否
HY-10260A Vandetanib trifluoroacetate / 否
Clinical Phase
生物活性分子 (7)
目录号 产品名 作用方式
纯度 Phase
HY-10205 Cediranib 99.58% Phase 3
HY-100019 Rogaratinib Inhibitor 99.86% Phase 3
HY-13314 Tesevatinib Inhibitor 99.21% Phase 3
HY-13049 Cediranib maleate 99.95% Phase 3
HY-13034 Gandotinib Inhibitor 99.82% Phase 2
HY-10987A ENMD-2076 99.12% Phase 2
HY-10987 ENMD-2076 Tartrate 99.42% Phase 2
Pre-clinical Phase
生物活性分子 (12)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-116624 MAZ51 99.96% 否
HY-119933 RIPK1-IN-7 Inhibitor 98.56% 否
HY-145293 TNIK-IN-3 Inhibitor 99.88% 否
HY-15813 FIIN-1 Inhibitor 99.11% 否
HY-10260S Vandetanib-d6 / 否
HY-10260S1 Vandetanib-d4 / 否
HY-110272 Vatalanib succinate Inhibitor / 否
HY-155178 Antiproliferative agent-34 Inhibitor / 否
HY-RS04994 FLT4 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS04995 Flt4 Mouse Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS04996 Flt4 Rat Pre-designed siRNA Set A Pre-designed Sets / 否
HY-10260S2 Vandetanib-13C6 / 否

直系同源

种属 基因名 来源 基因 ID
Homo sapiens FLT4 NCBI NCBI:2324
Mus musculus FLT4 NCBI NCBI:14257
Rattus norvegicus FLT4 NCBI NCBI:114110
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z